M. Blom, W. Kievit, J. Fransen, I. Kuper, A. Broeder et al., The Reason for Discontinuation of the First Tumor Necrosis Factor (TNF) Blocking Agent Does Not Influence the Effect of a Second TNF Blocking Agent in Patients with Rheumatoid Arthritis, The Journal of Rheumatology, vol.36, issue.10, pp.2171-2178, 2009.
DOI : 10.3899/jrheum.090054

P. Tak and J. Kalden, Advances in rheumatology: new targeted therapeutics, Arthritis Res Ther, vol.13, issue.1, p.5, 2011.

K. Upchurch and J. Kay, Evolution of treatment for rheumatoid arthritis, Rheumatology, vol.51, issue.suppl 6, pp.28-36, 2012.
DOI : 10.1093/rheumatology/kes278

M. Boissier, Cell and cytokine imbalances in rheumatoid synovitis, Joint Bone Spine, vol.78, issue.3, pp.230-234, 2011.
DOI : 10.1016/j.jbspin.2010.08.017

C. Fournier, Where Do T Cells Stand in Rheumatoid Arthritis?, Joint Bone Spine, vol.72, issue.6, pp.527-559, 2005.
DOI : 10.1016/j.jbspin.2004.12.012

P. Dieudé, Rheumatic diseases: Environment and genetics, Joint Bone Spine, vol.76, issue.6, pp.602-609, 2009.
DOI : 10.1016/j.jbspin.2009.10.002

M. Bax, J. Van-heemst, T. Huizinga, and R. Toes, Genetics of rheumatoid arthritis: what have we learned?, Immunogenetics, vol.7, issue.Suppl 3, pp.459-66, 2011.
DOI : 10.1007/s00251-011-0528-6

H. Deshmukh, X. Kim-howard, and S. Nath, Replication of recently identified associated single-nucleotide polymorphisms from six autoimmune diseases in Genetic Analysis Workshop 16 rheumatoid arthritis data, BMC Proceedings, vol.3, issue.Suppl 7, p.31, 2009.
DOI : 10.1186/1753-6561-3-s7-s31

G. Lettre and J. Rioux, Autoimmune diseases: insights from genome-wide association studies, Human Molecular Genetics, vol.17, issue.R2, pp.116-137, 2008.
DOI : 10.1093/hmg/ddn246

J. Anaya, The autoimmune tautology, Arthritis Research & Therapy, vol.12, issue.6, p.147, 2010.
DOI : 10.1186/ar3175

J. Hafler, L. Maier, J. Cooper, V. Plagnol, A. Hinks et al., CD226 Gly307Ser association with multiple autoimmune diseases, Genes and Immunity, vol.49, issue.1, pp.5-10, 2009.
DOI : 10.1038/nature06258

P. Dieudé, M. Guedj, M. Truchetet, J. Wipff, L. Revillod et al., Association of the CD226 Ser307 variant with systemic sclerosis: Evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis, Arthritis & Rheumatism, vol.69, issue.Suppl 47, pp.1097-105, 2011.
DOI : 10.1002/art.30204

A. Maiti, X. Kim-howard, P. Viswanathan, L. Guillén, X. Qian et al., Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility to multiple autoimmune diseases, Rheumatology, vol.49, issue.7, pp.1239-1283, 2010.
DOI : 10.1093/rheumatology/kep470

Z. Qiu, K. Zhang, X. Qiu, M. Zhou, and W. Li, CD226 Gly307Ser association with multiple autoimmune diseases: A meta-analysis, Human Immunology, vol.74, issue.2, pp.249-55, 2013.
DOI : 10.1016/j.humimm.2012.10.009

Y. Du, L. Shen, L. Yu, Y. Song, J. Zhu et al., The CD226 gene in susceptibility of rheumatoid arthritis in the Chinese Han population, Rheumatology International, vol.17, issue.3, pp.1299-304, 2012.
DOI : 10.1007/s00296-011-1796-z

R. Liu, N. Xu, X. Wang, L. Shen, G. Zhao et al., Influence of MIF, CD40, and CD226 polymorphisms on risk of rheumatoid arthritis, Molecular Biology Reports, vol.23, issue.Suppl 7, pp.6915-6937, 2012.
DOI : 10.1007/s11033-012-1518-y

H. Deshmukh, A. Maiti, X. Kim-howard, A. Rojas-villarraga, J. Guthridge et al., Evaluation of 19 Autoimmune Disease-associated Loci with Rheumatoid Arthritis in a Colombian Population: Evidence for Replication and Gene-Gene Interaction, The Journal of Rheumatology, vol.38, issue.9, pp.1866-70, 2011.
DOI : 10.3899/jrheum.110199

T. Suzuki, K. Ikari, Y. Kawaguchi, K. Yano, T. Iwamoto et al., Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility in Japanese rheumatoid arthritis patients, Modern Rheumatology, vol.45, issue.1, pp.200-202, 2013.
DOI : 10.3109/s10165-012-0609-x

A. Shibuya, D. Campbell, C. Hannum, H. Yssel, K. Franz-bacon et al., DNAM-1, A Novel Adhesion Molecule Involved in the Cytolytic Function of T Lymphocytes, Immunity, vol.4, issue.6, pp.573-81, 1996.
DOI : 10.1016/S1074-7613(00)70060-4

M. Boissier, L. Semerano, S. Challal, N. Saidenberg-kermanac-'h, and G. Falgarone, Rheumatoid arthritis: From autoimmunity to synovitis and joint destruction, Journal of Autoimmunity, vol.39, issue.3, pp.222-230, 2012.
DOI : 10.1016/j.jaut.2012.05.021

A. Fasth, N. Björkström, M. Anthoni, K. Malmberg, and V. Malmström, T cells in patients with rheumatoid arthritis, European Journal of Immunology, vol.1, issue.2, pp.378-87, 2010.
DOI : 10.1002/eji.200939399

L. Myers, E. Rosloniec, M. Cremer, and A. Kang, Collagen-induced arthritis, an animal model of autoimmunity, Life Sciences, vol.61, issue.19, pp.1861-78, 1997.
DOI : 10.1016/S0024-3205(97)00480-3

J. Courtenay, M. Dallman, A. Dayan, A. Martin, and B. Mosedale, Immunisation against heterologous type II collagen induces arthritis in mice, Nature, vol.61, issue.5748, pp.666-674, 1980.
DOI : 10.1038/283666a0

F. Durie, R. Fava, and R. Noelle, Collagen-induced arthritis as a model of rheumatoid arthritis, Clin Immunol Immunopathol, vol.73, issue.1, pp.11-19, 1994.

S. Gilfillan, C. Chan, M. Cella, N. Haynes, A. Rapaport et al., DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors, The Journal of Experimental Medicine, vol.298, issue.13, pp.2965-73, 2008.
DOI : 10.1016/S0006-291X(03)01560-2

L. Guéry, F. Batteux, N. Bessis, M. Breban, M. Boissier et al., Expression of Fas ligand improves the effect of IL-4 in collagen-induced arthritis, European Journal of Immunology, vol.30, issue.1, pp.308-323, 2000.
DOI : 10.1002/1521-4141(200001)30:1<308::AID-IMMU308>3.0.CO;2-X

J. Inglis, G. Criado, M. Medghalchi, M. Andrews, A. Sandison et al., Collagen-induced arthritis in C57BL/6 mice is associated with a robust and sustained T-cell response to type II collagen, Arthritis Research & Therapy, vol.9, issue.5, p.113, 2007.
DOI : 10.1186/ar2319

I. Campbell, J. Hamilton, and I. Wicks, Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis, European Journal of Immunology, vol.30, issue.6, pp.1568-75, 2000.
DOI : 10.1002/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R

J. Avouac, M. Elhai, M. Tomcik, B. Ruiz, M. Friese et al., Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis, Annals of the Rheumatic Diseases, vol.72, issue.6, pp.1089-98, 2013.
DOI : 10.1136/annrheumdis-2012-201759

S. Tahara-hanaoka, K. Shibuya, H. Kai, A. Miyamoto, Y. Morikawa et al., Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor, Blood, vol.107, issue.4, pp.1491-1497, 2006.
DOI : 10.1182/blood-2005-04-1684

Y. Yamashita, F. Abe, R. Hirochika, S. Tahara-hanaoka, A. Shibuya et al., Establishment and Characterization of a Novel Anti-DNAM-1 Monoclonal Antibody, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, vol.32, issue.1, pp.60-64, 2013.
DOI : 10.1089/mab.2012.0083

S. Glatigny, M. Blaton, S. Mencher, S. Mistou, B. Lucas et al., regulation of Th-1/Th-17 responses, European Journal of Immunology, vol.32, issue.2, pp.460-469, 2010.
DOI : 10.1002/eji.200939566

M. Elhai, A. Jérôme, C. Marchiol, R. G. Ruiz, B. Fréchet et al., Performance of Skin Ultrasound to Measure Skin Involvement in??Different Animal Models of Systemic Sclerosis, Ultrasound in Medicine & Biology, vol.39, issue.5, pp.845-52, 2013.
DOI : 10.1016/j.ultrasmedbio.2012.12.002

G. Clavel, C. Marchiol-fournigault, R. G. Boissier, M. Fradelizi, D. Bessis et al., Ultrasound and Doppler micro-imaging in a model of rheumatoid arthritis in mice, Annals of the Rheumatic Diseases, vol.67, issue.12, pp.1765-72, 2008.
DOI : 10.1136/ard.2007.083915

N. Saidenberg-kermanac-'h, N. Bessis, D. Lemeiter, M. De-vernejoul, M. Boissier et al., Interleukin-4 Cellular Gene Therapy and Osteoprotegerin Decrease Inflammation-Associated Bone Resorption in Collagen-Induced Arthritis, Journal of Clinical Immunology, vol.24, issue.4, pp.370-378, 2004.
DOI : 10.1023/B:JOCI.0000029116.12371.bf

G. Song, S. Bae, S. Choi, J. J. Lee, and Y. , Association between the CD226 rs763361 polymorphism and susceptibility to autoimmune diseases: a meta-analysis, Lupus, vol.175, issue.14, pp.1522-1552, 2012.
DOI : 10.1177/1352458510384011

E. Gan, A. Mitchell, K. Macarthur, and S. Pearce, The role of a nonsynonymous CD226 (DNAX-accessory molecule-1) variant (Gly 307Ser) in isolated Addison???s disease and autoimmune polyendocrinopathy type 2 pathogenesis, Clinical Endocrinology, vol.11, issue.2, pp.165-173, 2011.
DOI : 10.1111/j.1365-2265.2011.04030.x

T. Nabekura, K. Shibuya, E. Takenaka, H. Kai, K. Shibata et al., Critical role of DNAX accessory molecule-1 (DNAM-1) in the development of acute graft-versus-host disease in mice, Proceedings of the National Academy of Sciences, vol.107, issue.43, pp.18593-18601, 2010.
DOI : 10.1073/pnas.1005582107

J. Anaya, L. Gómez, and J. Castiblanco, Is there a Common Genetic Basis for Autoimmune Diseases?, Clinical and Developmental Immunology, vol.13, issue.2-4, pp.2-4185, 2006.
DOI : 10.1080/17402520600876762

V. Dardalhon, A. Schubart, J. Reddy, J. Meyers, L. Monney et al., CD226 Is Specifically Expressed on the Surface of Th1 Cells and Regulates Their Expansion and Effector Functions, The Journal of Immunology, vol.175, issue.3, pp.1558-65, 1950.
DOI : 10.4049/jimmunol.175.3.1558

H. Kai, K. Shibuya, Y. Wang, H. Kameta, T. Kameyama et al., Critical role of M. tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice, Immunology, vol.26, issue.2, pp.233-242, 2006.
DOI : 10.1016/S1074-7613(00)00070-4